Search results
Showing 46 to 60 of 117 results for anticoagulation
Various modes used to reinforce NICE guidance for venous thrombo-embolism prophylaxis
technology services' helped publish a screen saver based reminder about the anticoagulation policy recommendations on all networked...
This guideline covers managing hip fracture in adults. It aims to improve care from the time people aged 18 and over are admitted to hospital through to when they return to the community. Recommendations emphasise the importance of early surgery and coordinating care through a multidisciplinary Hip Fracture Programme to help people recover faster and regain their mobility.
identified by a consensus survey, for the perioperative management of anticoagulation treatment in people taking a vitamin K antagonist...
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
Evidence-based recommendations on aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease in adults. This involves replacing the diseased part of the valve with some of the person’s own pericardium.
View recommendations for IPG769Show all sections
Dronedarone for the treatment of non-permanent atrial fibrillation (TA197)
Evidence-based recommendations on dronedarone (Multaq) for treating non-permanent atrial fibrillation in adults.
identifying the cause and initiating appropriate secondary prevention (anticoagulation in case of atrial fibrillation or AF) To increase...
The effect of COVID-19 related lockdown on patients taking warfarin
are tested at their GP surgery they may not have any contact with the anticoagulation team regarding such issues We noted that pre COVID...
Recommendation ID NG208/22 Question Anticoagulation and antiplatelet therapy: What is the clinical and cost effectiveness of single or
This indicator covers the proportion of patients with acute myocardial infarction who were discharged on dual antiplatelet therapy. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG95
Chronic heart failure in adults: diagnosis and management (NG106)
This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.
This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots, including deep vein thrombosis and pulmonary embolism) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.
any of the following apply: Indications for thrombolysis or early anticoagulation treatment. On anticoagulant treatment. A known...
of Unknown Source (ESUS) Patients considered suitable for long term anticoagulation Modified Rankin Score (mRs) ≤3 See key learning...
Evidence-based recommendations on thoracoscopic exclusion of the left atrial appendage in atrial fibrillation (with or without other cardiac surgery) for the prevention of thromboembolism. This involves inserting a camera and instruments through small cuts in the chest and closing the left atrial appendage.
View recommendations for IPG400Show all sections
Sections for IPG400